|
|
fresh~horses wrote:
> Last month:
> The head of the Agency of Women's Health at the FDA, Dr. Susan Wood,
> resigned over the FDA's refusal to make the morning after pill OTC.
> http://www.washingtonpost.com/wp-dyn/content/article/2005/08/31/AR2005083101271.html
>
>
>
> Last week:
> The FDA appointed a male veterinarian as acting director to fill Dr.
> Susan Wood's position. Then, after flack from women's groups, they
> unappointed him and denied they'd ever appointed him but... .
> www.tompaine.com/print/fda_shenanigans.php">http://www.tompaine.com/print/fda_shenanigans.php
> (follow links within)
>
>
>
> Today:
> The brand new still-wet-behind-the-ears head of the FDA abruptly
> resigned.
> nytimes.com/2005/09/24/politics/24fda.html?hp&ex=1127534400&en=0072cec972013931&ei=5094&partner=homepage">http://nytimes.com/2005/09/24/politics/24fda.html?hp&ex=1127534400&en=0072cec972013931&ei=5094&partner=homepage
>
>
>
> It was the best of times. It was the worst of times.
COMMENT:
It was the dumbest of times. The FDA's OTC regulatory and application
policies resulted in a situation where, for nearly two decades, the
only safe non-drowsiness producing antihistamine was only by
prescription, not OTC. While meanwhile we struggled along with OTC
antihistamines that put people to sleep at the wheel, and other
prescription antihistamines that were still sedating or (even worse)
lethal causes of heart arrhythymias. This situation was so bad it
finally got to the point that one HMO company (Wellpoint) actually
petitioned the FDA to make ANOTHER company's drug available OTC.
Don't get your knickers in a twist thinking the recent FDA
foot-dragging might be some kind anti-female agenda. You're not being
singled out. The FDA has an effective anti-human agenda-- it's just
that this time women happen to be the segment of humans bearing the
regulatory problems. Never explain with complex politics and trickery
and bigotry what can more adequately be explained by simply
beaurocratic intertia, sloth, and simple stupidity. There's plenty of
the last to go around at the FDA.
SBH
|
|